Pharma News, 2016

JERSEY CITY, NJ, USA I October 05, 2016 I Drug development company SCYNEXIS, Inc.

Johnson & Johnson is telling patients that it has learned of a security vulnerability in one of its insulin pumps that a hacker could exploit to overdose diabetic patients with insulin, though it ...

Acute myeloid leukemia is a difficult disease to treat under the best of circumstances, and the subtype containing internal tandem duplication of fms-like tyrosine kinase 3 (FLT3-ITD) tends to...

The U.

LAWRENCEVILLE, NJ, USA I October 4, 2016 I Asana BioSciences, LLC, an oncology-focused, clinical stage biopharmaceutical company, today announced that the FDA has accepted the IND application for ASN0...

Three pioneers in the development of nanomachines, made of moving molecules, were awarded the Nobel Prize in Chemistry on Wednesday.

Samsung BioLogics has always said it will become the big deal in large-molecule manufacturing.

When Pascal Soriot took the reins at AstraZeneca in 2013, he plucked out Brilinta as a growth product.

Novo Nordisk, pressured by U.

BOSTON, MA, USA I September 28, 2016 I Vertex Pharmaceuticals Incorporated (Nasdaq.

Boehringer Ingelheim will co-develop ViraTherapeutics’ oncolytic virus therapy platform and lead candidate vesicular stomatitis virus glycoprotein (VSV-GP) the companies said today.

GSK today announced that Brian McNamara, is appointed Chief Executive Officer (CEO) of GSK’s Consumer Healthcare division effective immediately.